BNGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bionano Genomics Inc (BNGO) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators suggest a neutral to bearish trend, there are no significant positive catalysts or trading signals, and the company's financial performance shows declining profitability despite revenue growth. Given the lack of strong positive sentiment or signals, it is advisable to hold off on investing in this stock for now.
The MACD is slightly positive but contracting, indicating limited momentum. The RSI is neutral at 45.381, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.118, with support at 1.091 and resistance at 1.144. Overall, the technical trend is weak and does not indicate a strong buy signal.
Revenue increased by 21.31% YoY in Q3 2025, indicating some growth in the company's operations.
Net income dropped by -80.78% YoY, EPS fell by -94.86% YoY, and gross margin declined significantly by -132.89% YoY. No recent news or significant trading trends from hedge funds, insiders, or congress. The stock has a 50% chance of declining in the next week.
In Q3 2025, revenue increased to $7,367,000 (up 21.31% YoY), but net income dropped to -$8,503,000 (-80.78% YoY), EPS fell to -1.59 (-94.86% YoY), and gross margin declined to 45.74 (-132.89% YoY). The company is struggling with profitability despite revenue growth.
No recent analyst rating or price target changes are available.
